tirzepatide affect period How Semaglutide and Your Menstrual Cycle Shed | Does tirzepatide affect

Clinical Trials - Key findings Type 2 diabetes (40 weeks): HbA1c 1.241.48% (vs 0.41% placebo) Weight loss 4.57.6% (vs 1.7% placebo) Obesity without diabetes (72 weeks): Mean weight loss 11.2% 54.6% achieved 10% weight loss Improved cardiometabolic markers Efficacy similar to semaglutide/liraglutide (slightly less than tirzepatide) Safety: GI effects most common (during dose escalation) Low discontinuation rates No major hypoglycemia, hepatic, or CV safety signals so far Orforglipron combines oral convenience + GLP-1level efficacy, with the potential to improve access, adherence, and long-term outcomes in diabetes and obesity management

Nat Metab 8 , 13501367 (2026)

However, microdosing is considered an off-label approach, and medical reviews and guidelines stress the need for caution

Additional research into its uses, effectiveness, and side effects is ongoing